“Eclecticism in Psychiatric Care; Sequel to 2020”
September 25-26, 2026 – The San Luis Resort Spa & Conference Center, Galveston, TX

                                                 

Meeting Schedule

OVERVIEW

FRIDAY, SEPT 25TH 

4:00 – 8:00 pm              Exhibit and Poster Hours​

4:30 – 7:15 pm              Early Bird Reception​

5:00 – 8:00 pm              Registration Opens​

7:15 – 8:30/45 pm         CME Program

 

SATURDAY, SEPT 26TH

7:00 – 8:30 am              Early Breakfast​

8:00 – 10:30 am            Registration Opens​

8:00 – 1:00 pm              Exhibit and Poster Hours​

8:30 – 8:45 am              Welcome and Introductions, Elissa​

9:00 – 9:45 am              Please note: NON-CME Talk, West Mainsail*​

9:45 – 10:15 am            Welcome and Introductions, Elissa

10:15 – 10:40 am          Break​

10:40 – 1:00 pm            CME Program, Elissa​

1:15 – 2:45 pm              Luncheon​

1:30 – 2:30/45 pm         CME Program, East Mainsail

​

 

FRIDAY, SEPT 25TH 

 

7:00 – 7:15 pm              Opening Remarks

​

7:15 – 8:30/45 pm         Musical CME: High, Low, and In Between: Townes Van Zandt and UTMB Psychiatry
                                       Dwight Wolf, M.D.
                                       Objectives: The learning objectives for this activity have been designed to address

                                       clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Examine the historical psychiatric treatment of a high-profile patient and discuss

                                             how approaches to psychiatric care have evolved over time.
                                             ● Discuss the universality of stress and mental illness and their impact across

                                             diverse personal, social, and professional circumstances.
                                             ● Improve treatment effectiveness by better use of patients’ treatment experiences

                                             in past treatment eras.

​

8:45 – 9:00 pm              Closing Remarks

​

SATURDAY, SEPT 26TH

 

8:30 – 8:45 am               Opening Remarks​

​​​

9:00 – 9:45 am              History of Science and Advance in Antidyskinesia Treatment*
(Please note:                 Bunmi Cordero, FNP-BC, CPL/Neurocrine Biosciences
NON –CME                  Objectives: The learning objectives for this activity have been designed to address
Session,                         clinician competence. Upon conclusion of the activity participants should be able to:
West Mainsail*)                  ● Distinguish treatment responses to antipsychotic movement disorder side

                                               effects.

                                             ● Gain knowledge of a new mechanism of action for dyskinesia treatment.
                                             ● Have greater ability to distinguish treatment choices for dyskinesia from similar

                                             symptoms such as akathisia.           

​

9:45 – 10:15 am            Overview: The History of Psychiatry, Psychoanalysis, and Neuroscience; and the

                                      Technical Implications of Modern Treatment Gary Malone, M.D.

                                      Objectives: The learning objectives for this activity have been designed to address

                                      clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Understand the intersection of psychoanalytic theory and neuroscience.

                                             ● Improve major psychotherapy skills as part of practice.

​

10:15 – 10:35 am           Refreshment Break with Exhibitors

​

10:40 – 11:35 am          Historical Perspectives: ECT, Indoklon, and Insulin Coma; From the 1930’s to Today;

                                      and Present-Day Competitors to ECT Having the Best 5-10 Year Outcomes

                                      Mustafa Husain, M.D.

                                      Objectives: The learning objectives for this activity have been designed to address

                                      clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Understand why ECT as effective treatment has stood the test of time.
                                             ● Learn the 3 to 5 year post-treatment results of new somatic therapies.
                                             ● Improve knowledge of how much Ketamine’s long-term (multi-year) benefit

                                             ​versus risk relative to placebo.

​​

11:35 – 12:30 pm         Understanding and Integrating Psychotherapy with General Psychiatry

                                      Gary Malone, M.D.

                                      Objectives: The learning objectives for this activity have been designed to address

                                      clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Describe how biological, psychoanalytic, cognitive, and behavioral theories

                                             contribute to the theoretical framework of modern psychotherapy.
                                             ● Explain how neuroscience and psychoanalytic principles can be integrated to

                                             address the mind, body, and spirit in comprehensive psychiatric care.
                                             ● Apply a comprehensive approach to psychiatric treatment that integrates

                                             medication management, psychotherapy, spirituality, and life-goal coaching.

​​​

12:30 – 1:00 pm          The 100 Year Old UTMB Galveston Department of Psychiatry:

                                     Its 5 Chairs and Their Legacies Kelly Caldwell, MLIS, CA

                                     Objectives: The learning objectives for this activity have been designed to address

                                     clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Describe the founding and early development of the UTMB Galveston

                                             Department of Psychiatry, including the establishment of its pioneering psychiatric

                                             residency program.
                                             ● Identify key contributions and legacies of the department’s leadership that

                                             influenced psychiatric education, research, and clinical practice.
                                             ● Improve C&A referral skills based on the pioneering of clinical and research

                                             efforts by Drs. Grace Jameson and Karen Wagner, respectively, at UTMB.

                                                ​​

1:15 – 2:45 pm             Luncheon

​

1:30 – 2:30 pm             Panel on the Psychiatrist’s Identity and Roles: The Last 50 Years, the Next 50 Years
                                     Note: (3) brief talks are followed by 30 minutes discussion.
                                     Richard Weddige, MD: “The Psychiatrist as a Soul Doctor”
                                     Alcides Amador, MD: “Update: The Treatment of ADHD in Children/Adolescents;

                                     Adult Persistence”
                                     Alcides Amador, MD: “The Future Training of Psychiatrists”
                                     Mustafa Husain, MD, panelist
                                     Gary Malone, MD, panelist

                                     Objectives: The learning objectives for this activity have been designed to address

                                     clinician competence. Upon conclusion of the activity participants should be able to:
                                             ● Examine the evolving identity of the psychiatrist as a caring physician,

                                             distinguishing enduring professional values from roles and responsibilities likely to

                                             change in the future.
                                             ● Identify emerging roles psychiatrists may assume in the delivery and

                                             coordination of future patient care.

                                             ● Describe the roles of external trigeminal nerve stimulation (eTNS) and

                                             prescription digital therapeutics in the treatment of ADHD.
                                             ● Explain the mechanism of action of centanafadine and its potential role in the

                                             treatment of ADHD.
                                             ● Identify at least three emerging skill sets that future psychiatry residents will need

                                             to develop as psychiatric practice evolves.
                                             ● Identify at least three enduring professional qualities that will remain essential to

                                             the practice of psychiatry over the next 50 years.

​

2:30 – 2:45 pm             Closing Remarks

​​

*Please note: the talk titled “History of Science and Advance in Antidyskinesia Treatment” is not accredited and is not available for CME I credit. It is a presentation by Neurocrine Biosciences, and may only be used as Credit II, but not Credit I.

​

TITUS HARRIS SOCIETY’S 2026 CME MEETING occurs in the centennial year of the Department of Psychiatry at UTMB, founded by Dr. Titus Harris, and proposes to update students, residents, and clinicians on antipsychotics and their side effects, psychodynamic theory and therapeutic application, historical and current use of somatic therapies, and both the roots and the changes in the roles of a psychiatrist.

CME PROGRAM GOAL / TARGET AUDIENCE This live activity has been designed in a format consisting of case study presentations, lectures and direct discussion to provide its primary target audience of psychiatrists, as well as other specialties of medicine, with the most up-to- date, evidence-based data that can be translated into clinical practice. Information and data will address new developments in treatments and new directions in research to address the professional practice gaps of the learners and advance the physicians’ competence and effective use of targeted skills so that they may develop strategies to apply the knowledge, skills and judgement of the information presented in the educational activity into their practice. The learning objectives for this activity have been designed to address clinician competence.

NEEDS ASSESSMENT TSPP has incorporated into this CME activity the relevant educational needs concerning competence that underline the professional practice gaps of our participants.

ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the Essential Areas accreditation requirements and policies of the Texas Medical Association (TMA) through the Joint Providership of the Texas Society of Psychiatric Physicians and the Titus Harris Society. TSPP is accredited by the TMA to provide continuing education for physicians.

CREDIT STATEMENT The Texas Society of Psychiatric Physicians designates this Live Activity for a maximum of five and a quarter (5.25) AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate with the extent of their participation in this activity.

FACULTY AND PLANNERS DISCLOSURE POLICY The Texas Society of Psychiatric Physicians will disclose to participants the existence of any relevant financial relationships between faculty members, TSPP staff and members, who planned, authored, contributed to, and/or reviewed the content of this activity, and any commercial interest discussed in this educational activity. Disclosure will occur through written communication in the syllabus/handout material.

​

 

Revised September 18, 2026

​

​